Medication Assisted Treatment
DBHIDS is continuing its concerted efforts to increase the availability of Medication Assisted Treatment (MAT) in all forms across all levels of care. Medication-assisted treatments (MAT) are empirically supported as effective interventions to treat opioid addiction and include methadone, buprenorphine, and naltrexone XR (aka Vivitrol).
In addition to increasing the treatment capacity, DBHIDS is employing a more comprehensive response to opioid addiction by transforming the practice of detoxification to withdrawal management. Withdrawal management provides medical interventions in combination with appropriate psychosocial supports to ensure safer and more successful transitions from illicit substance use.
Multiple studies have proven that MAT, in combination with psychosocial treatment is effective in:
- Reducing mortality
- Lessening illicit opioid use
- Increasing retention in treatment
- Lowering criminal justice consequences of substance use
- Diminishing overall health care and societal costs
DBHIDS is linking individuals to a MAT treatment provider to align with evidence-based practice and improve outcomes related to the opioid epidemic. Numerous studies have shown that MAT is more effective than detoxification followed by “drug free” treatment.
MAT Treatment Locations in Philadelphia
If you or someone you know needs help with opioid addiction, start by going to one of the MAT providers below for an assessment. MAT locations, including contact information and the services available per location, can be viewed on the map below. If you would like additional information about any of the locations, click the following icon on the Google Map:
- The National Council for Behavioral Health Medication Assisted Treatment information page
- Substance Abuse and Mental Health Services Administration Medication Assisted Treatment Campaign
- The Mayor’s Task Force to Combat the Opioid Epidemic in Philadelphia
- DBHIDS Fact Sheet: Advancing the Substance Use Disorder Treatment Continuum